Dr. Ginpreet Kaur

Qualification              : M. Pharm., Ph.D.

Specialization             : Pharmacology

E mail                         : ginpreet.kaur@nmims.edu  

Phone                         : 022-42332000 (Extn-2035)

Experience                 : 20 years  

Dr. Ginpreet Kaur has completed her M. Pharm (Pharmacology) from Delhi Institute of Pharmaceutical Science and Research (DIPSAR), Delhi University and PhD from SPP SPTM SVKM NMIMS University. She has executed research projects in the area of Neuropharmacology and Metabolic Syndrome.

Interest areas:

• Screening of different synthetic and herbal medicines used for the treatment of Parkinson’s disease. Alzheimer’s disease.
• Exploring the effects of nutraceuticals in Metabolic Syndrome
• Screening of antidiabetic and Anticancer activity using cell lines
• Exploring the role of synthetic medicine in zebrafish model.
• Phytochemical ingredient screening for anti-oxidant, anti-inflammatory, anti-diabetic effects.

Research

• Publications – 135 (International-120, National-15)
• Books- 3
• Book Chapters- 51
• Patents- NA
• Presentations-85 (International-51, National-34)
• Government funded projects – 4

Completed

• Principal investigator for Project entitled "Exploring the role of the Emoxypine succinate in neuroinflammation induced Alzheimer’s disease by suppressing NLRP3 inflammasome pathway” sanctioned by Science & Engineering Research Board (SERB), Dept. of Science & Technology, Govt. of India,36 months, Rs. 29,01,360/-.
• Principal investigator for Project entitled "Innovative approach to target Type 2 Diabetes Mellitus: CB2 agonist combined with L-Arginine” Department of Science and Technology Science & Engineering Research Board, Govt of India,36 months, Rs.24,86,350/-
• Co-investigator for Project entitled "Application of Radiotracer in evaluating the therapeutic potential of Morinda genus for dementia” Department of Atomic Energy, Board of Research in Nuclear Sciences(BRNS), Govt of India,36 months,22,81,000/-
• Co-PI of for Project entitled "Evaluation of Neuroprotective potential of Majun Nisyan: a mechanistic study” sanctioned by Central council of research in Unani Medicine, Ministry of AYUSH, 36 months,31,00,000/- in 2021.

University funded project-01

• Completed

Completed research proposal entitled "Exploring the role of the trans-anethole in neuro-inflammation induced Alzheimer’s disease rodent model by suppressing NLRP3 inflammasome pathway sanctioned by Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM’s NMIMS (Deemed to be University) of Rs.1,00,000/-.

Industry projects-03

• Completed

Completed Ethix Pharma funded project entitled Memory enhancing effect of test product by amyloid beta (Aβ1-42) induced cognitive impairment in aged rats of Rs. 2,21,200/-, 2 months, March 2022.

Co-investigator for Ethix Pharma funded project entitled Efficacy Study of Test sample against H. pylori infection + PGE2 and Urease determination” of Rs.2,00,000/-, 2 months, August 2013.

Co-investigator for Ethix Pharma funded project entitled "In-Vivo Anti- Inflammatory Dose Response Study of Polygonum Minus (Kesum) Extract In Wistar Albino Rats”of Rs.40,000/- in 2012

Conferences/Workshops/Seminars attended- 85

Academic activities

She has guided 23 no. of M. Pharm. students for their research projects.

She has guided 4 no. of PhD students successfully and 5 no. candidates are registered under her supervision.

 Awards

1. Featured in the "Top 2% Scientist of the World” list by Stanford University in Association with Elsevier in 2023, 2024 and 2025.
2. Best Oral Presentation Award for paper entitled "Zebrafish model for Iron Induced Alzheimer's Disease” was presented at 6th Nirma Institute of Pharmacy International Conference Jointly Organized with Indian Pharmacological Society, February 17-19, 2022.
3. Prof C.C Kartha travel award for Oral Presentation during International Conference of Cardiovascular Sciences (ICCS-2020) from February 21–23, 2020, at Delhi Pharmaceutical Sciences and Research University, Delhi.
4. SPER WF-Young teacher award during 4 ^th   annual International conference of Society of Pharmaceutical Education and research held on February 27^th and 28^th 2015 at DIT University, Dehradun.
5. "Best Oral Presentation Award” for scientific paper entitled "Evaluation of Antihyperlipidemic potential of Lagenaria Siceraria and Trigonella Foenum graceum in rats” at the 2nd Annual Conference of Society of Pharmaceutical education and Research at Jamia Hamdard, Hamdard University, and Delhi held on 9th March, 2013
6. Best Faculty award from SPP School of Pharmacy and Technology Management, SVKM’S NMIMS University in Year 2012
7. Awarded by "Dr.R.D. Kulkarni Prize”: for scientific paper entitled "α-Glucosidase inhibitory activity of curcumin and curcumin in combination with piperine and quercetin" at Fourth International Conference On "Innovations in Translating Technologies   through Clinical Pharmacology”, Organized by South Asian Chapter of American College of Clinical Pharmacology, 10th to 12th December 2010, Sahyadri Guest House, Malabar Hill, Mumbai. December, 2010
8. ‘Dr. Ashok B. Vaidya Prize’ for scientific paper entitled "Antihyperlipidemic potential of combinatorial extract of curcumin in triton – induced Hyperlipidemia in rats” at Third International Annual Conference on ‘Drug Discovery & Development – Challenges in Partnership’, Organized by South Asian Chapter of American College of Clinical Pharmacology, 2nd, 3rd & 4th October, 2009

Professional Memberships

• Lifetime Membership of the Indian Pharmacological Society, Indian Society of hypertension, Indian Pharmaceutical Association, APTI, International Academy of Cardiovascular Sciences.
• Nominated as Council member of Society of Pharmaceutical education and Research (SPER) Women’s forum Council. Nominated as Topic Editor for frontier journal Phytochemical-based Nanoformulations to Tackle Drug Resistance in Cancer, Phytochemical-based Nanoformulations to Tackle Drug Resistance in Cancer, Plant-Derived Natural Products: Towards Novel Interventions for Neurodegenerative Diseases, and  COVID-19: New Variants and Host Demography. Guest Associate Editor for Pharmacology of Anti-Cancer Drugs

Recent Publications

1. Bagwe Parab, S., Kaur, G. Development of Zebrafish model for Iron Induced Neuroinflammation. Fish Physiol Biochem 51, 160 (2025). https://doi.org/10.1007/s10695-025-01575-y {Impact Factor: 2.5}
2. Soni, S., & Kaur, G. (2025). Emerging Therapeutics Targeting the PI3K/Akt/GSK-3β in Calcium Dysregulation in Alzheimer’s Disease. Cell Calcium, 103107. https://doi.org/10.1016/j.ceca.2025.103107 {Impact Factor: 4.0}
3. Soni, S., Kaur, G. Emerging therapeutic application of clemastine: a review of recent patents updates. Naunyn-Schmiedeberg's Arch Pharmacol 398, 9609–9622 (2025). https://doi.org/10.1007/s00210-025-03978-3 {Impact Factor: 3.1}
4. Thawkar BS, Kaur G. Betanin, in conjunction with virgin coconut oil, suppresses lipopolysaccharide-induced neuroinflammation in C57BL mice by modulating the NLRP3 inflammasome pathway. Minerva Biotechnol Biomol Res 2025;37:36-47. doi: 10.23736/S2724-542X.24.03153-5 {Impact factor: 3.031}
5. Parab, Siddhi Bagwe, and Ginpreet Kaur. "Emoxypine succinate modulates behavioral and molecular responses in zebrafish model of iron Overload-Induced neuroinflammation via CDK5/GSK3-β and NLRP3 inflammasome pathway." Brain research 1846: 149236. https://doi.org/10.1016/j.brainres.2024.149236. {Impact Factor: 2.7}
6. Awate, S. A., & Kaur, G. (2025). Exploring therapeutic targets in Toll-like receptor pathways: Implications for cardiovascular management in polycystic ovary syndrome. European Journal of Pharmacology, 1001, 177749. https://doi.org/10.1016/j.ejphar.2025.177749. {Impact Factor: 4.1}
7. Ahire C, Kaur G. Targeting the P2X7 receptor signaling pathway: Unlocking therapeutic strategies for autism spectrum disorder. Brain Behav Immun Health. 2025;47:101037. Published 2025 Jun 16. doi:10.1016/j.bbih.2025.101037 {Impact Factor: 3.5}
8. Thawkar, Baban S., and Ginpreet Kaur. "Betanin combined with virgin coconut oil inhibits neuroinflammation in aluminum chloride-induced toxicity in rats by regulating NLRP3 inflammasome." Journal of Traditional and Complementary Medicine (2024).14, no.3 ;287-299. doi: 10.23736/S2724-542X.24.03153-5{Impact Factor: 4.5}
9. Kumawat, Vivek S., and Ginpreet Kaur. "Cannabinoid receptor 2 (CB2) agonists and L-arginine ameliorate diabetic nephropathy in rats by suppressing inflammation and fibrosis through NF-κβ pathway." Naunyn-Schmiedeberg's archives of pharmacology 397, no. 1 (2024): 381-393. https://doi.org/10.1007/s00210-023-02597-0. {Impact Factor: 3.60}
10. Thawkar, Baban S., and Ginpreet Kaur. "Betanin mitigates scopolamine-induced cognitive impairment by restoring cholinergic function, boosting brain antioxidative status, and increasing BDNF level in the zebrafish model." Fish Physiology and Biochemistry 49, no. 2 (2023): 335-349. https://doi.org/10.1007/s10695-023-01185-6. {Impact Factor: 2.90}